XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   46,880    
Beginning balance at Dec. 31, 2021 $ 170,462 $ 553,902 $ (154) $ (383,286)
Increase (Decrease) in Shareholders' Equity        
Net loss (7,091)     (7,091)
Stock-based compensation expense 9,531 $ 9,531    
Stock option exercises (in shares)   125    
Stock option exercises 1,155 $ 1,155    
Shares issued under the Employee Stock Purchase Plan (in shares)   9    
Shares issued under the Employee Stock Purchase Plan 310 $ 310    
Issuance of stock for restricted stock unit vesting (in shares)   108    
Restricted stock withheld for employee tax remittance (in shares)   (41)    
Restricted stock withheld for employee tax remittance (1,423) $ (1,423)    
Unrealized gain (loss) on investment (459)   (459)  
Ending balance (in shares) at Mar. 31, 2022   47,081    
Ending balance at Mar. 31, 2022 172,485 $ 563,475 (613) (390,377)
Beginning balance (in shares) at Dec. 31, 2021   46,880    
Beginning balance at Dec. 31, 2021 170,462 $ 553,902 (154) (383,286)
Increase (Decrease) in Shareholders' Equity        
Net loss (22,631)      
Unrealized gain (loss) on investment (992)      
Ending balance (in shares) at Sep. 30, 2022   47,201    
Ending balance at Sep. 30, 2022 177,837 $ 584,900 (1,146) (405,917)
Beginning balance (in shares) at Mar. 31, 2022   47,081    
Beginning balance at Mar. 31, 2022 172,485 $ 563,475 (613) (390,377)
Increase (Decrease) in Shareholders' Equity        
Net loss (8,963)     (8,963)
Stock-based compensation expense 10,808 $ 10,808    
Stock option exercises (in shares)   32    
Stock option exercises 428 $ 428    
Shares issued under the Employee Stock Purchase Plan (in shares)   10    
Shares issued under the Employee Stock Purchase Plan 318 $ 318    
Issuance of stock for restricted stock unit vesting (in shares)   19    
Restricted stock withheld for employee tax remittance (in shares)   (1)    
Restricted stock withheld for employee tax remittance (18) $ (18)    
Unrealized gain (loss) on investment (242)   (242)  
Ending balance (in shares) at Jun. 30, 2022   47,141    
Ending balance at Jun. 30, 2022 174,816 $ 575,011 (855) (399,340)
Increase (Decrease) in Shareholders' Equity        
Net loss (6,577)     (6,577)
Stock-based compensation expense 9,104 $ 9,104    
Stock option exercises (in shares)   41    
Stock option exercises 498 $ 498    
Shares issued under the Employee Stock Purchase Plan (in shares)   15    
Shares issued under the Employee Stock Purchase Plan 331 $ 331    
Issuance of stock for restricted stock unit vesting (in shares)   6    
Restricted stock withheld for employee tax remittance (in shares)   (2)    
Restricted stock withheld for employee tax remittance (44) $ (44)    
Unrealized gain (loss) on investment (291)   (291)  
Ending balance (in shares) at Sep. 30, 2022   47,201    
Ending balance at Sep. 30, 2022 $ 177,837 $ 584,900 (1,146) (405,917)
Beginning balance (in shares) at Dec. 31, 2022 47,253 47,253    
Beginning balance at Dec. 31, 2022 $ 192,272 $ 593,245 (978) (399,995)
Increase (Decrease) in Shareholders' Equity        
Net loss (7,495)     (7,495)
Stock-based compensation expense 8,731 $ 8,731    
Stock option exercises (in shares)   132    
Stock option exercises 2,009 $ 2,009    
Shares issued under the Employee Stock Purchase Plan (in shares)   11    
Shares issued under the Employee Stock Purchase Plan 216 $ 216    
Issuance of stock for restricted stock unit vesting (in shares)   183    
Restricted stock withheld for employee tax remittance (in shares)   (72)    
Restricted stock withheld for employee tax remittance (2,097) $ (2,097)    
Unrealized gain (loss) on investment 342   342  
Ending balance (in shares) at Mar. 31, 2023   47,507    
Ending balance at Mar. 31, 2023 $ 193,978 $ 602,104 (636) (407,490)
Beginning balance (in shares) at Dec. 31, 2022 47,253 47,253    
Beginning balance at Dec. 31, 2022 $ 192,272 $ 593,245 (978) (399,995)
Increase (Decrease) in Shareholders' Equity        
Net loss (16,175)      
Unrealized gain (loss) on investment $ 515      
Ending balance (in shares) at Sep. 30, 2023 47,684 47,684    
Ending balance at Sep. 30, 2023 $ 204,380 $ 621,013 (463) (416,170)
Beginning balance (in shares) at Mar. 31, 2023   47,507    
Beginning balance at Mar. 31, 2023 193,978 $ 602,104 (636) (407,490)
Increase (Decrease) in Shareholders' Equity        
Net loss (5,020)     (5,020)
Stock-based compensation expense 8,761 $ 8,761    
Stock option exercises (in shares)   68    
Stock option exercises 889 $ 889    
Shares issued under the Employee Stock Purchase Plan (in shares)   18    
Shares issued under the Employee Stock Purchase Plan 384 $ 384    
Issuance of stock for restricted stock unit vesting (in shares)   26    
Restricted stock withheld for employee tax remittance (in shares)   (3)    
Restricted stock withheld for employee tax remittance (79) $ (79)    
Unrealized gain (loss) on investment 15   15  
Ending balance (in shares) at Jun. 30, 2023   47,616    
Ending balance at Jun. 30, 2023 198,928 $ 612,059 (621) (412,510)
Increase (Decrease) in Shareholders' Equity        
Net loss (3,660)     (3,660)
Stock-based compensation expense 7,924 $ 7,924    
Stock option exercises (in shares)   50    
Stock option exercises 787 $ 787    
Shares issued under the Employee Stock Purchase Plan (in shares)   13    
Shares issued under the Employee Stock Purchase Plan 329 $ 329    
Issuance of stock for restricted stock unit vesting (in shares)   8    
Restricted stock withheld for employee tax remittance (in shares)   (3)    
Restricted stock withheld for employee tax remittance (86) $ (86)    
Unrealized gain (loss) on investment $ 158   158  
Ending balance (in shares) at Sep. 30, 2023 47,684 47,684    
Ending balance at Sep. 30, 2023 $ 204,380 $ 621,013 $ (463) $ (416,170)